Hong Shen
About Hong Shen
Hong Shen is the Associate Director at Bristol-Myers Squibb in Princeton, NJ, with a background in pharmacokinetics and pharmaceutical sciences. He has over 80 research publications and has received multiple awards for his contributions to drug metabolism and pharmacokinetics.
Title and Current Role
Hong Shen is the Associate Director at Bristol-Myers Squibb. He is based in Princeton, NJ, where he oversees various research and development projects.
Previous Positions at Bristol-Myers Squibb
Hong Shen has a long history with Bristol-Myers Squibb. He served as a Principal Scientist from 2017 to 2019 in Princeton, NJ. Before that, he was a Senior Research Investigator from 2011 to 2017, also at Princeton, NJ. He began his tenure at the company as a Research Investigator from 2006 to 2011 in Hopewell, NJ.
Educational Background
Hong Shen earned his Doctor of Philosophy (Ph.D.) in Pharmacokinetics and Pharmaceutical Sciences from the University of Michigan. He studied there from 2002 to 2006, focusing on the quantitative translation of preclinical data to clinical findings.
Committee Memberships
Hong Shen is an active member of several professional committees. He currently serves on the International Transporter Consortium (ITC), the ISSX Transporter Focus Group, the Pharmaceutical IQ DMLG/CPLG Transporter Working Group, and the North Jersey Drug Metabolism Discussion Group (NJDMDG). He was also on the organizing committee for the AAPS Drug Transporter Focus Group from 2014 to 2018.
Awards and Recognitions
Hong Shen has received the James Gillette Drug Metabolism and Pharmacokinetics Awards from the American Society for Pharmacology and Experimental Therapeutics in 2001, 2007, and 2018. His work has been widely recognized in the field.
Publications and Research Interests
Hong Shen has over 80 research publications and book chapters to his name. His research focuses on applying mechanism-based approaches for the quantitative translation of preclinical in vitro and in vivo data to clinical findings.